BioWorld

June 23, 2003

View Archived Issues

Genentech, Tanox Receive FDA Approval For Asthma Therapeutic

Genentech Inc. and partners Tanox Inc. and Novartis Pharma AG said late Friday the FDA approved Xolair, a first-in-class monoclonal antibody for moderate to severe persistent asthma in adults and adolescents. (BioWorld Today) Read More

President Bush Among Headliners At BIO Conference In Washington

Read More

Genetically Tinkered Coffee Beans Produce Decaffeinated Brew Minus Alkaloid's Undesirable Side Effects

Read More

Discovery Laboratories Raises $27.M To Advance Surfactant

Read More

Hollis-Eden Raises $15M Via Private Placement Of Stock

Read More

Other News To Note

Read More